KANEQ PHARMA INC has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are RETROPHIN INC, CHAI TECH CORP and ATLANTHERA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | New Zealand | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 | |
#9 | India | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Han Yongxin | 14 |
#2 | Leblanc Yves | 8 |
#3 | Therien Michel | 8 |
#4 | Lau Cheuk K | 6 |
#5 | Colucci John | 6 |
#6 | Dufresne Claude | 6 |
#7 | Belley Michel | 6 |
#8 | Wilson Marie-Claire | 6 |
#9 | Bayly Christopher | 5 |
#10 | Claude Dufresne | 1 |
Publication | Filing date | Title |
---|---|---|
CA2870488A1 | Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors | |
NZ600947A | Fused Aromatic Difluoromethanephosphonates as Protein Tyrosine Phosphatase 1B (PTP-1B) Inhibitors |